These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 3456786)

  • 1. Adult acute lymphoblastic leukaemia: a study of prognostic features and response to treatment over a ten year period.
    Marcus RE; Catovsky D; Johnson SA; Gregory WM; Talavera JG; Goldman JM; Galton DA
    Br J Cancer; 1986 Feb; 53(2):175-80. PubMed ID: 3456786
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of acute lymphoblastic leukaemia in adults.
    Barnett MJ; Greaves MF; Amess JA; Gregory WM; Rohatiner AZ; Dhaliwal HS; Slevin ML; Biruls R; Malpas JS; Lister TA
    Br J Haematol; 1986 Nov; 64(3):455-68. PubMed ID: 3466641
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Remission continuation therapy for adult acute lymphoblastic leukemia. Preliminary results with a multidrug treatment protocol.
    Rossi G; Verzura P; Marpicati P; Zaniboni A; Ferremi P; Marini G; Marinone G
    Chemioterapia; 1984 Jun; 3(3):147-51. PubMed ID: 6597732
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improved survival of infants less than 1 year of age with acute lymphoblastic leukemia treated with intensive multiagent chemotherapy.
    Reaman GH; Steinherz PG; Gaynon PS; Bleyer WA; Finklestein JZ; Evans R; Miller DR; Sather HN; Hammond GD
    Cancer Treat Rep; 1987 Nov; 71(11):1033-8. PubMed ID: 3315194
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of acute lymphoblastic leukemia in adults: results of the L-10 and L-10M protocols.
    Schauer P; Arlin ZA; Mertelsmann R; Cirrincione C; Friedman A; Gee TS; Dowling M; Kempin S; Straus DJ; Koziner B
    J Clin Oncol; 1983 Aug; 1(8):462-70. PubMed ID: 6583321
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Medical Research Council leukaemia trial--UKALL V: an attempt to reduce the immunosuppressive effects of therapy in childhood acute lymphoblastic leukemia. Report to the Council by the Working Party on Leukaemia in Childhood.
    Chessells JM; Durrant J; Hardy RM; Richards S
    J Clin Oncol; 1986 Dec; 4(12):1758-64. PubMed ID: 3537216
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Salvage by timed sequential chemotherapy in primary resistant acute myeloid leukemia: analysis of prognostic factors.
    Revesz D; Chelghoum Y; Le QH; Elhamri M; Michallet M; Thomas X
    Ann Hematol; 2003 Nov; 82(11):684-90. PubMed ID: 12928754
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of adult lymphoblastic leukaemia using cyclical chemotherapy with three combinations of four drugs (COAP, POMP, TRAP schedule).
    Proctor SJ; Finney R; Walker W; Thompson RB
    Postgrad Med J; 1981 Jan; 57(663):19-22. PubMed ID: 6944694
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic importance of myelosuppression during maintenance treatment of lymphoblastic leukaemia. Leukaemia in Childhood Working Party of the Medical Research Council.
    Dolan G; Lilleyman JS; Richards SM
    Arch Dis Child; 1989 Sep; 64(9):1231-4. PubMed ID: 2684039
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term survival in acute lymphoblastic leukaemia in adults treated according to the LALA 87 protocol.
    Colović M; Bogdanović A; Janković G; Kraguljac N; Suvajdzić N
    Chemotherapy; 2003 Jun; 49(3):138-45. PubMed ID: 12815207
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DNA-thioguanine nucleotide concentration and relapse-free survival during maintenance therapy of childhood acute lymphoblastic leukaemia (NOPHO ALL2008): a prospective substudy of a phase 3 trial.
    Nielsen SN; Grell K; Nersting J; Abrahamsson J; Lund B; Kanerva J; Jónsson ÓG; Vaitkeviciene G; Pruunsild K; Hjalgrim LL; Schmiegelow K
    Lancet Oncol; 2017 Apr; 18(4):515-524. PubMed ID: 28258828
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of acute lymphoblastic leukemia in children. Long-term results of two trials.
    Cáp J; Koza I; Misíková Z; Foltinová A; Strbáková E
    Neoplasma; 1983; 30(1):81-92. PubMed ID: 6339961
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of prognostic factors in newly diagnosed acute promyelocytic leukemia treated with all-trans retinoic acid and chemotherapy. Japan Adult Leukemia Study Group.
    Asou N; Adachi K; Tamura J; Kanamaru A; Kageyama S; Hiraoka A; Omoto E; Akiyama H; Tsubaki K; Saito K; Kuriyama K; Oh H; Kitano K; Miyawaki S; Takeyama K; Yamada O; Nishikawa K; Takahashi M; Matsuda S; Ohtake S; Suzushima H; Emi N; Ohno R
    J Clin Oncol; 1998 Jan; 16(1):78-85. PubMed ID: 9440726
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of high-risk acute lymphoblastic leukemia in children using the AL851 and ALHR88 protocols: a report from the Kyushu-Yamaguchi Children's Cancer Study Group in Japan.
    Matsuzaki A; Ishii E; Okamura J; Eguchi H; Yoshida N; Yanai F; Inoue T; Miyake K; Ishihara T; Tsuboi C
    Med Pediatr Oncol; 1996 Jan; 26(1):10-9. PubMed ID: 7494507
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Teniposide plus cytarabine improves outcome in childhood acute lymphoblastic leukemia presenting with a leukocyte count greater than or equal to 100 x 10(9)/L.
    Dahl GV; Rivera GK; Look AT; Hustu HO; Kalwinsky DK; Abromowitch M; Mirro J; Ochs J; Murphy SB; Dodge RK
    J Clin Oncol; 1987 Jul; 5(7):1015-21. PubMed ID: 3474355
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acute lymphoblastic leukemia in infants less than one year of age: a cumulative experience of the Children's Cancer Study Group.
    Reaman G; Zeltzer P; Bleyer WA; Amendola B; Level C; Sather H; Hammond D
    J Clin Oncol; 1985 Nov; 3(11):1513-21. PubMed ID: 3863894
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Consolidation therapy without maintenance for acute non-lymphoblastic leukaemia.
    Roberts MM; Juttner CA; Blunden RW; Horvath N; To LB; Ho JQ; Dart GW; Kimber RJ
    Med J Aust; 1988 Feb; 148(4):181-3. PubMed ID: 3340044
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Adult acute lymphoblastic leukemia: preliminary results of the LAL-86 protocol].
    Ribera JM; Grañena A; Rozman C; Urbano-Ispizua A; Bladé J; Carreras E; Cervantes F; Marín P; Sierra J; Nomdedeu B
    Sangre (Barc); 1990 Feb; 35(1):26-32. PubMed ID: 2333581
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alternating pulses of vincristine-prednisone with cytarabine-cyclophosphamide versus vincristine-prednisone in the maintenance therapy of acute lymphoblastic leukemia.
    Sackmann Muriel F; Svarch E; Pavlovsky S; Bustelo P; Giuntoli J; Vergara B; Garay G; Eppinger-Helft M; Kvicala R; Dibar E
    Cancer Treat Rep; 1984 Apr; 68(4):581-6. PubMed ID: 6370428
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Four-agent induction and intensive asparaginase therapy for treatment of childhood acute lymphoblastic leukemia.
    Clavell LA; Gelber RD; Cohen HJ; Hitchcock-Bryan S; Cassady JR; Tarbell NJ; Blattner SR; Tantravahi R; Leavitt P; Sallan SE
    N Engl J Med; 1986 Sep; 315(11):657-63. PubMed ID: 2943992
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.